BioTek Instruments, Inc., a part of Agilent Technologies, is a global leader in the development, manufacture and distribution of life science instrumentation, including imaging & microscopy, multi-mode detection, liquid handling and automation systems. Our philosophy transcends conventional thinking and challenges the status quo. We develop fresh, original solutions by unifying concepts that often appear to be opposed. It means to shape and reshape. To engineer, build, deliver and support products that best serve the marketplace by providing what you need, when you need it.
Think Possible. It’s the difference between leading and following.
CELLINK is the world-leading bioconvergence company creating the future of medicine by providing technologies, products and services to create, understand, and master biology.
In 2016, we commercialized the world’s first universal bioink - an innovation 8 years in the making - which spurred our rapid rise to becoming the world’s leading bioprinting company. Fast-forward to 2021, after five successful acquisitions and several high-profile product launches, we are much more than a bioprinting company. We have embraced the emerging bio-convergence revolution, which is leveraging synergistic breakthroughs in the life sciences and technology to meet the world’s growing healthcare needs. By combining advances in biology, engineering, big data and AI, we are now the top bio-convergence company in the world, creating the future of medicine.
The Cell and Gene Therapy Catapult was established as an independent centre of excellence to advance the growth of the UK cell and gene therapy industry, by bridging the gap between scientific research and full-scale commercialisation. With more than 350 employees focusing on cell and gene therapy technologies, it works with partners in academia and industry to ensure these life-changing therapies can be developed for use in health services throughout the world. It offers leading-edge capability, technology and innovation to enable companies to take products into clinical trials and provide clinical, process development, manufacturing, regulatory, health economics and market access expertise. Its aim is to make the UK the most compelling and logical choice for UK and international partners to develop and commercialise these advanced therapies. The Cell and Gene Therapy Catapult works with Innovate UK. For more information please visit https://ct.catapult.org.uk or visit https://www.gov.uk/innovate-uk.
Fluicell is an innovative life science company dedicated to providing single-cell microfluidic research tools and services for scientists worldwide. We deliver easy-to-use solutions for your research needs in single-cell biology, electrophysiology, single-cell bioprinting and tissue modelling. Fluicell's novel bioprinting technology, commercialized under the name Biopixlar®, is a completely new type of bioprinter with the unique capability to position cells in three dimensions with high resolution and precision. Based on innovative Fluicell technology, Biopixlar is capable of generating detailed, multi-cellular biological tissues, directly in native cell culture media. Biopixlar is all-in-one discovery platform that will help researchers around the globe to build novel tissue models for drug development, disease understanding and regenerative medicine research.
A revolutionary platform for regenerative medicine
Our jellyfish collagen-based innovation addresses complex regenerative medical needs, shaping next generation treatments and supporting current and future scientific research.
At the heart of our products is marine-sourced Collagen Type 0, an evolutionary ancient stem collagen that is foundational, allowing greater applications across multiple indications.
Unlike alternative collagens which are more specific therefore compromising their end applications, Collagen Type 0 is more versatile due to its evolutionary lineage. For this reason, it can be classed as the “stem of all collagens”.
PeproTech creates the building blocks of your life science research by manufacturing high-quality products that advance scientific discovery and human health. Since 1988, we have grown into a global enterprise with state-of-the-art manufacturing facilities in the US, and offices around the world.
With over 2,000 products, PeproTech has developed and refined innovative protocols to ensure quality, reliability and consistency.
Our mission is to provide the highest quality products and premium support that address the needs and demands of today's scientists and researchers.
We pride ourselves on being a trusted partner within the scientific community.
Institute for Regeneration and Repair, University of Edinburgh
The Centre for Regenerative Medicine (CRM) is a research centre based at the University of Edinburgh's Institute for Regeneration and Repair.
Our Scientists and clinicians study stem cells, disease and tissue repair to advance human health. Research at the Centre is aimed at developing new treatments for major diseases including cancer, heart disease, liver failure, and degenerative diseases such as multiple sclerosis and Parkinson's.
The Centre is located in the Edinburgh BioQuarter, a site shared by the Royal Infirmary Hospital and the University's Clinical Research facilities. This makes us ideally placed to translate basic science into clinical therapies.
Foster outstanding learning and scholarship, producing graduates equipped for and inspired towards high personal and professional achievement
Enhance the scientific, cultural and economic wellbeing of society through the discipline of engineering, contributing to the quality of life and fulfilling the aspirations of global humanity
Pursue and perform research of the highest quality, motivated by both intellectual curiosity and societal needs
Over 250 staff and 2500 students sit within five teaching Disciplines and seven Research Institutes covering the breadth and depth of world-leading engineering.
Our engineering courses enable students to use their skills, intelligence and creativity to tackle any engineering challenge. The School is one of the most industrially-engaged within the University, with graduates providing a higher-than-average economic impact when they enter the workplace.
